Key facts
- This page summarizes Richard N. Kender's Form 4 filing for BICYCLE THERAPEUTICS PLC (BCYC).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 06 Jan 2025, 19:30.
Richard N. Kender - 02 Jan 2025 Form 4 Insider Report for BICYCLE THERAPEUTICS PLC (BCYC)
- Reporting relationship
- Director
- Issuer ticker
- BCYC
- Reported as of
- 02 Jan 2025
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 06 Jan 2025, 19:30:10 UTC
- Prior SEC filing
- 21 Jun 2024
- Next SEC filing
- 11 Apr 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Jason Minio, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Richard N. Kender filed Form 4 for BICYCLE THERAPEUTICS PLC (BCYC) on 06 Jan 2025.
Change
- Previous filing in this sequence was filed on 21 Jun 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
BCYC
transaction
Ordinary Shares
Award
- Transaction value
- $0
- Shares
- +6,250
- Change %
- +37%
- Price
- $0.000000
- Shares after
- 23,000
- Date
- 02 Jan 2025
- Ownership
- Direct
- Footnotes
- F1, F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
BCYC
transaction
Derivative
Stock Option (right to buy)
Award
- Transaction value
- $0
- Shares
- +12,500
- Change %
- Price
- $0.000000
- Shares after
- 12,500
- Date
- 02 Jan 2025
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
- 12,500
- Exercise price
- $14.00
- Footnotes
- F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Represents a restricted stock unit ("RSU") award. The RSUs shall vest in four equal installments on March 15, 2025, June 15, 2025, September 15, 2025 and December 15, 2025.
Footnote F2
Each RSU represents a contingent right to receive one ordinary share.
Footnote F3
This option shall vest in four equal installments on March 15, 2025, June 15, 2025, September 15, 2025 and December 15, 2025.